Immunomic Therapeutics: Funding, Investors & Team (Oct 2026)
Immunomic Therapeutics is a biotechnology company in the development stage that creates vaccines using lysosomal associated membrane proteins to address allergies and other health concerns in humans. Established in 2005, the company is located in Lancaster, Pennsylvania.
Immunomic Therapeutics has raised $6.5M across 1 funding round on record, the most recent an undisclosed round of $6.5M announced in Jun 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Immunomic Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Immunomic Therapeutics Funding Rounds
Immunomic Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Immunomic Therapeutics Funding Compared to Other Biotechnology Startups
Immunomic Therapeutics' latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immunomic Therapeutics in Biotechnology and Lancaster
Companies Similar to Immunomic Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Immunomic Therapeutics Funding FAQs
What does Immunomic Therapeutics do?
Immunomic Therapeutics is a biotechnology company in the development stage that creates vaccines using lysosomal associated membrane proteins to address allergies and other health concerns in humans. Established in 2005, the company is located in Lancaster, Pennsylvania.
How much funding has Immunomic Therapeutics raised?
Immunomic Therapeutics has raised $6.5M across 1 round on record. The most recent is an undisclosed round of $6.5M announced in Jun 2025.
When did Immunomic Therapeutics last raise funding?
Immunomic Therapeutics' most recent funding round on record is an undisclosed round of $6.5M, announced in Jun 2025.
Who founded Immunomic Therapeutics?
FundedIQ lists William G Hearl (Founder) at Immunomic Therapeutics.
Where is Immunomic Therapeutics headquartered?
Immunomic Therapeutics is based in Lancaster, Pennsylvania, United States.
How many employees does Immunomic Therapeutics have?
Immunomic Therapeutics is in the 11-50 employee band.
How does Immunomic Therapeutics' funding compare to other Biotechnology startups?
Immunomic Therapeutics' latest round of $6.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Immunomic Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immunomic Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.